Skip to main content

Animations

MJFF Publications

2691 - 2700 of 9131 Results
Title
Year
  • Year
  • 2017
  • 2017
  • 2019
  • 2017
  • 2018
  • 2018
  • 2025
  • 2020
  • 2019
  • 2018
  • Summary Details
    OPEN
    Title: GBA mutations in Parkinson disease: earlier death but similar neuropathological features
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/ene.13395
    Citation Count: 35
  • Summary Details
    OPEN
    Title: Single low doses of MPTP decrease tyrosine hydroxylase expression in the absence of overt neuron loss
    Journal Name: NeuroToxicology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuro.2017.03.008
    Citation Count: 51
  • Summary Details
    OPEN
    Title: Brain expression of the vascular endothelial growth factor gene family in cognitive aging and alzheimer’s disease
    Journal Name: Molecular Psychiatry
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41380-019-0458-5
    Citation Count: 160
  • Summary Details
    OPEN
    Title: Heritability of hippocampal subfield volumes using a twin and non-twin siblings design
    Journal Name: Human Brain Mapping
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/hbm.23654
    Citation Count: 30
  • Tissue engineered nigrostriatal pathway for treatment of Parkinson's disease
    2018
    Summary Details
    RESTRICTED
    Title: Tissue engineered nigrostriatal pathway for treatment of Parkinson's disease
    Journal Name: Journal of Tissue Engineering and Regenerative Medicine
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/term.2698
    Citation Count: 63
  • Summary Details
    OPEN
    Title: TLR5 decoy receptor as a novel anti-amyloid therapeutic for Alzheimer’s disease
    Journal Name: Journal of Experimental Medicine
    Publisher: Rockefeller University Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-sa
    DOI - Digital Object Identifier: 10.1084/jem.20180484
    Citation Count: 104
  • Summary Details
    OPEN
    Title: Constipation in a Large Online Cohort of Persons with Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.70168
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Synthesis and characterization of high affinity fluorogenic α-synuclein probes
    Journal Name: Chemical Communications
    Publisher: Royal Society of Chemistry (RSC)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1039/c9cc09849f
    Citation Count: 37
  • High-Spatial-Resolution Diffusion MRI in Parkinson Disease: Lateral Asymmetry of the Substantia Nigra
    2019
    Summary Details
    RESTRICTED
    Title: High-Spatial-Resolution Diffusion MRI in Parkinson Disease: Lateral Asymmetry of the Substantia Nigra
    Journal Name: Radiology
    Publisher: Radiological Society of North America (RSNA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1148/radiol.2019181042
    Citation Count: 57
  • Summary Details
    OPEN
    Title: Disease progression models for dominantly-inherited Alzheimer’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awy089
    Citation Count: 3
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.